BioWorld

Jan. 8, 2003

View Archived Issues

Sunesis, Biogen Collaborate Around Tethering Technology

Sunesis Pharmaceuticals Inc. will use its Tethering technology to discover therapeutics for inflammatory and autoimmune diseases in a collaboration with Biogen Inc. (BioWorld Today) Read More

PDL Enters Deal With MedImmune, Spells Out Development Strategy

Read More

Criticism Of FDA Unwarranted, Former Commissioner Says

Read More

Oculodentodigital Dysplasia Marshals Devastating Connexin 43 Genes From Nose To Toes

Read More

XenoPort, ALZA Form Alliance For Delivery Of Three Products

Read More

Correction

Read More

InterMune Falls On Survival Data From Actimmune Trial

Read More

Cephalon, MDS Sign Agreement On Proteomics-Based Research

Read More

Other News To Note

Read More